Filana Therapeutics, Inc. (NASDAQ: FLNA) — Healthcare · Share Price, Chart & Market Data
About: Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The company was incorporated in 1998 and is based in Austin, Texas.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.60 (-0.93%)
FLNAFilana Therapeutics, Inc.
Loading watchlist status…
Trade FLNA now
Filana Therapeutics, Inc. share price
FLNA price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 3:43 pm GMT+0
FLNA price performance
-6.176%
5D
-4.491%
1M
-23.684%
YTD
0.314%
1Y
FLNA price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 3:43 pm GMT+0
FLNA details
FLNA Market Signals